<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10670124</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Robles García, J E</dc:author>
<dc:author>Martín-Marquina Aspiunza, A</dc:author>
<dc:author>Sánchez Zalabardo, D</dc:author>
<dc:author>Rosell Costa, D</dc:author>
<dc:author>Berián Polo, J M</dc:author>
<dc:author>Arocena García-Tapia, J</dc:author>
<dc:author>Diez Caballero, F</dc:author>
<dc:author>Zudaire Bergera, J J</dc:author>
<dc:author>Sanz Pérez, G</dc:author>
<dc:description xml:lang="en">OBJECTIVES Margins involvement in T1-T2 patients undergoing radical prostatectomy is a negative prognostic factor. We aimed to: a) Study the clinical and pathological features of patients with surgical margins involvement; b) Elucidate the influence of margins involvement on the progression-free survival. MATERIAL AND METHOD The study included the group with "positive margins" out of a series of 160 patients with localised prostate adenocarcinoma who underwent radical prostatectomy at the Clínica Universitaria de Navarra between 1988-1997. statistics used: Fisher's or Pearson's test for qualitative variables. Kaplan-Meyer, Log-rank and Cox's multivariate tests for the survival study. RESULTS The group accounts for 28% (45/158) of all patients undergoing radical prostatectomy. Mean PSA (22 +/- 14 ng/ml) is similar to the remaining group although there is greater significant rates of PSA &gt; 15 ng/ml (p: 0.006), worse Gleason (p: 0.01), higher proportion of T2bc (p: 0.003) and node involvement (0.001). Progression-free survival (BPFS) is significantly lower in this group (32 +/- 12% vs 61 +/- 6% at 5 years). Margins are the single factor with higher influence (RR:5) in the multivariate study. Influence is clear in patients with Gleason &lt; 5 (0% vs 87%) and PSA &lt; 30 ng/ml (33 +/- 14 vs 70 +/- 7%), but has no influence on BPFS of patients with PSA &gt; 30 ng/ml or Gleason 5-10. CONCLUSIONS Positive margins in patients undergoing radical prostatectomy is associated to higher PSA, worse Gleason and higher stage. They are the most significant independent risk factor (except for PSA &gt; 30 ng/ml) for biochemical progression-free survival as evidenced in the multivariate study, although it is likely this influence is diluted in patients with PSA &gt; 30 ng/ml and/or Gleason 5-10.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1999 Nov-Dec </dc:date>
<dc:title xml:lang="es">Prostatectomía radical en adenocarcinoma de próstata clínicamente localizado. Estudio de los pacientes con márgenes positivos y su influencia en la supervivencia libre de progresión bioquímica.</dc:title>
<dc:title xml:lang="en">[Radical prostatectomy in clinically localized prostatic adenocarcinoma. Study of patients with positive margins and their impact on survival free from biochemical progression].</dc:title>
<dc:publisher>Actas urologicas espanolas</dc:publisher>
</metadata>
</record>
</pubmed-document>
